https://www.selleckchem.com/pr....oducts/zilurgisertib
asty. These results support current guidelines recommending a preoperative INR ≤ 1.5 for shoulder arthroplasty.Metastatic disease is the most common pathologic cause of bone destruction, and the upper extremity is frequently involved. This location presents many surgical challenges, but there have been several recent implant and technique-related advances that have improved outcomes. Patients can be treated nonsurgically, with radiation or with surgery, depending on patient characteristics, signs/symptoms, primary diagnos
Like
Comment
Share
